Global X Morningstar Global Technology ETF (TECH) Stock Price, News & Analysis

Company Overview

Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 5,275 shs
• Average Volume: N/A
• Market Capitalization: A$380.11 million
• P/E Ratio: N/A
• Dividend Yield: 5.87%
• Price Target: N/A
• Consensus Rating: N/A

TECH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Global X Morningstar Global Technology ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Morningstar Global Technology ETF investors own include AC Immune (ACIU), Achieve Life Sciences (ACHV), Acer Therapeutics (ACER), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Manufacturing
• Industry: Biological Product (Except Diagnostic) Manufacturing
• Sub-Industry: N/A
• Current Symbol: ASX:TECH
• CIK: N/A
• Web: www.bio-techne.com
• Phone: 16123798854
• Fax: N/A
• Employees: 2,300
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: A$380.11 million
• Optionable: Not Optionable
• Beta: N/A